Vitura Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vitura Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth47.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Oct 17
There's No Escaping Vitura Health Limited's (ASX:VIT) Muted Revenues Despite A 33% Share Price Rise

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Oct 13
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Sep 07
Vitura Health's (ASX:VIT) Soft Earnings Don't Show The Whole Picture

Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Aug 12
Vitura Health Limited's (ASX:VIT) 26% Dip In Price Shows Sentiment Is Matching Earnings

Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 12
Vitura Health Limited (ASX:VIT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Apr 25
The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27
Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Dec 13
Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21
Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Nov 01
Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Jul 18
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Sep 12
Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Sep 05
If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vitura Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:VIT - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024124467N/A
3/31/2024122689N/A
12/31/202312091111N/A
9/30/2023119121010N/A
6/30/202311714910N/A
3/31/202310712910N/A
12/31/20229710910N/A
9/30/20228281112N/A
6/30/20226761314N/A
3/31/20225451111N/A
12/31/202142599N/A
9/30/202132355N/A
6/30/202122111N/A
3/31/202115000N/A
12/31/20207-2-1-1N/A
9/30/20204-3-3-3N/A
6/30/20200-4-5-5N/A
3/31/20200-4-4-4N/A
12/31/2019N/A-4-4-4N/A
9/30/2019N/A-3-3-3N/A
6/30/2019N/A-3-2-2N/A
6/30/20180000N/A
6/30/201700N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VIT's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if VIT's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if VIT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if VIT's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if VIT's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VIT's Return on Equity is forecast to be high in 3 years time


Discover growth companies